查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1808931

橘皮組織治療市場，按治療類型、性別、年齡層、最終用戶、國家和地區分類 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率及預測

Cellulite Treatment Market, By Treatment Type, By Gender, By Age Group, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 316 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年橘皮組織治療市場規模價值 24.0233 億美元，2025 年至 2032 年的複合年成長率為 10.11%。

隨著美學意識的提升（尤其是女性），以及對非侵入性美容手術的需求不斷成長，橘皮組織治療市場正在穩步成長。久坐的生活方式、荷爾蒙變化和老化等因素導致橘皮組織高發，尤其是在女性群體中。雷射療法和射頻等非侵入性療法因其安全性和極短的恢復期而廣受歡迎。隨著消費者尋求價格實惠的替代方案，家用解決方案和外用產品的需求也呈現激增之勢。橘皮組織治療市場正在快速成長，這得益於技術創新、更廣泛的美學意識以及對非侵入性個人化解決方案日益成長的需求。然而，品牌和診所必須應對關鍵挑戰，尤其是在信任、價格承受能力和應對複雜的監管方面，才能將消費者的興趣轉化為永續的成長。

橘皮組織治療市場-市場動態

非侵入性美容手術的需求不斷成長

橘皮組織治療市場的主要驅動力之一是對非侵入性和微創美容手術的需求不斷成長。消費者越來越尋求效果顯著、不適感、恢復時間或風險最小的治療方法。根據美國整形外科醫師協會的數據，過去五年中，非侵入性美容手術增加了20%以上，凸顯人們明顯轉向更安全的門診治療。射頻、雷射治療和冷凍溶脂等技術因其非手術性質和相對較快的療效而被廣泛用於減少橘皮組織。根據美國國立衛生研究院 (NIH) 的最新調查，全球橘皮組織治療增加了3.4%，其中包括2023年由整形外科醫生實施的3,490萬例外科和非手術美容手術。全球實施的外科手術超過1,580萬例，非手術手術超過1,910萬例。隨著塑身和緊緻肌膚趨勢的持續成長，尤其是在25-45歲的女性群體中，全球對此類解決方案的需求也在成長，從而推動了整體市場的成長。

橘皮組織治療市場-關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年）全球市場預計年複合成長率約為 10.11%

根據治療類型細分，預計非侵入式治療將在 2024 年佔據最大市場佔有率

根據年齡段細分，18-30 歲是 2024 年的主要年齡段

根據最終用途細分，美容診所/醫療水療中心是 2024 年的主要最終用途

按地區分類，北美是 2024 年的主要收入來源

橘皮組織治療市場-細分分析：

全球橘皮組織治療市場根據治療類型、性別、年齡層、最終用戶和地區進行細分。

根據治療類型，市場分為三類：非侵入性、微創性和局部治療。在這三種治療類型中，非侵入性療法在橘皮組織治療市場中佔據主導地位。這主要歸功於其無痛、恢復時間短、風險低於手術治療的優勢。射頻、雷射和超音波等療法深受患者和醫生的青睞。隨著對快速、無需恢復期的臨床解決方案的需求日益成長，非侵入性療法已成為已開發市場和新興市場中最常用的療法。

根據最終用戶，市場可分為四類：醫院、皮膚科診所、美容診所/醫療水療中心以及家庭使用。在這四類最終用戶中，美容診所/醫療水療中心在橘皮組織治療市場佔據主導地位。這些機構專注於美容手術，並配備了先進的非侵入式技術，特別適合減少橘皮組織。它們提供舒適專業的環境和個人化的治療方案，吸引了大量尋求快速有效治療的患者。與醫院相比，它們價格實惠，且專注於美容護理，使其成為消費者最青睞的選擇。

橘皮組織治療市場—地理洞察

北美引領橘皮組織治療市場，這得益於消費者在美容手術上的高支出、先進的醫學美容基礎設施以及人們對非侵入性治療的廣泛認知。由於對塑身和抗衰老服務的需求不斷成長，美國佔據了主要佔有率。歐洲緊追在後，德國、法國和英國等國家對美容技術的採用程度很高。同時，亞太地區正在迅速崛起，這得益於中國、韓國和印度等國家日益增強的美容意識、不斷成長的可支配收入以及皮膚科服務涵蓋範圍的擴大。拉丁美洲、中東和非洲地區成長溫和，但由於城市化進程加快以及人們對美容外觀日益成長的興趣，該地區蘊藏著尚未開發的潛力。

橘皮組織治療市場-競爭格局：

橘皮組織治療市場較為分散，多家知名公司和新創企業在非侵入式、微創式和局部治療領域競爭。橘皮組織影響高達 90% 的女性，美國每年用於治療的資金超過 10 億美元。該領域的主要公司包括 Soliton, Inc.、Shockwave Medical, Inc.、輝瑞公司、Sesen Bio, Inc. 和波士頓科學公司。 Soliton 宣布，在其減少橘皮組織的概念驗證臨床試驗（「POC 試驗」）獲得積極資料後，決定推進一項針對橘皮組織的關鍵性試驗。這些公司正在投資射頻、雷射系統和注射解決方案等先進技術，以提高治療效果和患者滿意度。為了加強市場影響力，各公司之間進行策略合作、產品發布和區域擴張十分常見。艾爾建的注射療法 QWO(R) 和豪洛捷的 SculpSure(R) 雷射平台是備受矚目的創新產品，正在獲得市場關注。隨著對非手術美容解決方案的需求不斷成長，設備製造商和美容服務提供者之間的競爭日益激烈。

最新動態：

2024年11月，Tiger Aesthetics Medical, LLC宣布收購Revelle Aesthetics, Inc.，後者是突破性消脂設備Aveli的開發商，該設備已獲得FDA批准。此次收購將擴大Tiger Aesthetics在快速發展的再生身體美學領域的影響力，並透過先進的下半身年輕化解決方案補充其產品組合。

2021年5月，艾伯維（AbbVie）旗下公司艾爾建美學（Allergan Aesthetics）宣布以約5.5億美元收購Soliton Inc.，以擴大其橘皮組織治療產品組合。 Soliton的RESONIC快速聲波脈衝設備已獲得FDA批准，可用於非侵入性橘皮組織治療，臨床試驗中患者滿意度高達92.9%。此次收購是艾爾建現有的CoolSculpting Elite系列產品的補充。此舉鞏固了艾爾建在美學塑身市場的地位。

目錄

第1章：消脂治療市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 橘皮組織治療市場片段（依治療類型）
    • 橘皮組織治療市場按性別分類的片段
    • 橘皮組織治療市場按年齡細分
    • 橘皮組織治療市場片段（按最終用戶）
    • 各國橘皮組織治療市場概況
    • 橘皮組織治療市場（按地區）
  • 競爭洞察

第3章：消脂治療的主要市場趨勢

  • 橘皮組織治療市場促進因素
    • 市場促進因素的影響分析
  • 橘皮組織治療市場的限制
    • 市場限制的影響分析
  • 橘皮組織治療市場機遇
  • 橘皮組織治療市場未來趨勢

第4章：消脂治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：消脂市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：消脂治療市場格局

  • 2024年橘皮組織治療市佔分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：橘皮組織治療市場－依治療類型

  • 概述
    • 按治療類型分類的細分市場佔有率分析
    • 非侵入性
    • 微創
    • 外用

第 8 章：消脂治療市場 - 依性別

  • 概述
    • 按性別分類的細分市場佔有率分析
    • 女性
    • 男性

第9章：消脂治療市場－依年齡層

  • 概述
    • 按年齡層別分類的細分佔有率分析
    • 18-30歲
    • 31-45歲
    • 46-60歲
    • 60歲以上

第 10 章：橘皮組織治療市場 - 按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 醫院
    • 皮膚科診所
    • 美容診所/醫療水療中心
    • 家庭使用

第 11 章：消脂治療市場 - 按地區分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美消脂治療主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模和預測，按治療類型
    • 北美市場規模及預測（依性別）
    • 北美市場規模及預測（按年齡層）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲消脂治療主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模及預測（按治療類型）
    • 歐洲市場規模及預測（依性別）
    • 歐洲市場規模及預測（依年齡層）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區消脂治療主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依治療類型）
    • 亞太地區市場規模及預測（依性別）
    • 亞太地區市場規模及預測（依年齡層）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲的消脂治療關鍵製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按治療類型）
    • 拉丁美洲市場規模及預測（依性別）
    • 拉丁美洲市場規模及預測（按年齡層）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的消脂治療主要製造商
    • MEA 市場規模及預測（依國家/地區）
    • MEA 市場規模及預測（依治療類型）
    • MEA 市場規模及預測（依性別）
    • MEA 市場規模及預測（依年齡層）
    • MEA 市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 12 章：關鍵供應商分析-消脂治療產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • AbbVie Inc. (Allergan Aesthetics)
    • Lumenis Ltd.
    • Candela Medical
    • Solta Medical
    • Cynosure LLC
    • BTL Aesthetics
    • Cutera Inc.
    • Merz Pharmaceuticals
    • Endo International plc
    • Venus Concept Inc.
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5556

Cellulite Treatment Market size was valued at US$ 2,402.33 Million in 2024, expanding at a CAGR of 10.11% from 2025 to 2032.

The cellulite treatment market is experiencing steady growth due to rising aesthetic awareness, especially among women, and the increasing demand for non-invasive cosmetic procedures. Factors such as a sedentary lifestyle, hormonal changes, and aging contribute to the high prevalence of cellulite, particularly in the female population. Non-invasive treatments like laser therapy and radiofrequency are highly popular for their safety and minimal downtime. The market is also seeing a surge in at-home solutions and topical products as consumers seek affordable alternatives. The cellulite treatment market is growing fast, powered by technological innovation, broader aesthetic awareness, and rising demand for non-invasive, personalized solutions. However, brands and clinics must address critical challenges, especially around trust, affordability, and navigating regulatory complexity, to convert interest into sustainable growth.

Cellulite Treatment Market- Market Dynamics

Rising Demand for Non-Invasive Aesthetic Procedures

One of the primary drivers of the cellulite treatment market is the increasing demand for non-invasive and minimally invasive cosmetic procedures. Consumers increasingly seek treatments that offer visible results with minimal discomfort, recovery time, or risk. According to the American Society of Plastic Surgeons, non-invasive cosmetic procedures increased by over 20% in the last five years, highlighting a clear shift toward safer, outpatient treatments. Technologies like radiofrequency, laser therapy, and cryolipolysis are widely adopted for cellulite reduction due to their non-surgical nature and relatively quick results. As per the National Institute of Health (NIH), the latest survey reported a global increase of 3.4%, including 34.9 million surgical and nonsurgical aesthetic procedures performed by plastic surgeons in 2023. More than 15.8 million surgical procedures and more than 19.1 million nonsurgical procedures were performed worldwide. As body contouring and skin-tightening trends continue to grow, particularly among women aged 25-45, the demand for such solutions globally is rising, fueling overall market growth.

Cellulite Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.11% over the forecast period (2025-2032)

Based on Treatment Type segmentation, Non-Invasive was predicted to show maximum market share in the year 2024

Based on age group segmentation, 18-30 years was the leading age group in 2024

Based on end use segmentation, Aesthetic Clinics/Medical Spas was the leading end use in 2024

On the basis of region, North America was the leading revenue generator in 2024

Cellulite Treatment Market- Segmentation Analysis:

The Global Cellulite Treatment Market is segmented on the basis of Treatment Type, Gender, Age Group, End User, and Region.

The market is divided into three categories based on Treatment Type: Non-Invasive, Minimally Invasive, and Topical. Among the three treatment types, the Non-Invasive segment dominates the cellulite treatment market. This is largely due to its painless procedures, minimal recovery time, and lower risk compared to surgical options. Treatments like radiofrequency, laser therapy, and ultrasound are widely preferred by patients and practitioners alike. The increasing demand for quick, clinic-based solutions without downtime has made non-invasive methods the most adopted category in both developed and emerging markets.

The market is divided into four categories based on end user: Hospitals, Dermatology Clinics, Aesthetic Clinics/Medical Spas, and Home Use. Among the four end-user segments, Aesthetic Clinics/Medical Spas dominate the cellulite treatment market. These facilities specialize in cosmetic procedures and are equipped with advanced, non-invasive technologies preferred for cellulite reduction. They offer a comfortable, professional environment with personalized treatment plans, attracting a large number of patients seeking quick and effective results. Their affordability compared to hospitals and focus on beauty care make them the most popular choice among consumers.

Cellulite Treatment Market- Geographical Insights

North America leads the cellulite treatment market, driven by high consumer spending on cosmetic procedures, advanced medical aesthetics infrastructure, and widespread awareness of non-invasive treatments. The United States holds a major share due to the growing demand for body contouring and anti-aging services. Europe follows closely, with countries like Germany, France, and the UK showing strong adoption of aesthetic technologies. Meanwhile, the Asia-Pacific region is emerging rapidly, fueled by increasing beauty consciousness, rising disposable incomes, and expanding access to dermatology services in countries like China, South Korea, and India. Latin America and the Middle East & Africa show moderate growth but hold untapped potential due to growing urbanization and rising interest in appearance enhancement.

Cellulite Treatment Market- Competitive Landscape:

The cellulite treatment market is moderately fragmented, with several established companies and emerging players competing across non-invasive, minimally invasive, and topical segments. Cellulite affects up to 90% of women and over a billion dollars per year is spent on treatment in the US. Key companies in this space include Soliton, Inc., Shockwave Medical, Inc., Pfizer Inc., Sesen Bio, Inc., and Boston Scientific Corporation. Soliton has announced its decision to move forward with a pivotal trial in cellulite after positive data from its proof of concept clinical trial for the reduction of cellulite (the "POC Trial") confirmed. These companies are investing in advanced technologies like radiofrequency, laser systems, and injectable solutions to enhance treatment efficacy and patient satisfaction. Strategic collaborations, product launches, and regional expansions are common as companies aim to strengthen market presence. Allergan's injectable treatment, QWO(R), and Hologic's SculpSure(R) laser platform are notable innovations gaining market traction. With growing demand for non-surgical cosmetic solutions, competition is intensifying among device manufacturers and aesthetic service providers.

Recent Developments:

In November 2024, Tiger Aesthetics Medical, LLC announced the acquisition of Revelle Aesthetics, Inc., the developer of Aveli, a breakthrough FDA-cleared cellulite reduction device. This acquisition expands Tiger Aesthetics' presence in the fast-growing field of regenerative body aesthetics, complementing its portfolio with advanced solutions for lower body rejuvenation.

In May 2021, Allergan Aesthetics, an AbbVie company, announced the acquisition of Soliton Inc. for approximately $550 million to expand its cellulite treatment portfolio. Soliton's RESONIC Rapid Acoustic Pulse device, FDA-cleared for non-invasive cellulite treatment, showed 92.9% patient satisfaction in clinical trials. The acquisition complements Allergan's existing CoolSculpting Elite offerings. This move strengthens Allergan's position in the aesthetic body contouring market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL CELLULITE TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AbbVie Inc. (Allergan Aesthetics)
  • Lumenis Ltd.
  • Candela Medical
  • Solta Medical
  • Cynosure LLC
  • BTL Aesthetics
  • Cutera Inc.
  • Merz Pharmaceuticals
  • Endo International plc
  • Venus Concept Inc.
  • Others

GLOBAL CELLULITE TREATMENT MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Non-Invasive
  • Minimally Invasive
  • Topical

GLOBAL CELLULITE TREATMENT MARKET, BY GENDER- MARKET ANALYSIS, 2019 - 2032

  • Female
  • Male

GLOBAL CELLULITE TREATMENT MARKET, BY AGE GROUP - MARKET ANALYSIS, 2019 - 2032

  • 18-30 years
  • 31-45 years
  • 46-60 years
  • Above 60 years

GLOBAL CELLULITE TREATMENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Dermatology Clinics
  • Aesthetic Clinics/Medical Spas
  • Home Use

GLOBAL CELLULITE TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cellulite Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cellulite Treatment Market Snippet by Treatment Type
    • 2.1.2. Cellulite Treatment Market Snippet by Gender
    • 2.1.3. Cellulite Treatment Market Snippet by Age Group
    • 2.1.4. Cellulite Treatment Market Snippet by End User
    • 2.1.5. Cellulite Treatment Market Snippet by Country
    • 2.1.6. Cellulite Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Cellulite Treatment Key Market Trends

  • 3.1. Cellulite Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cellulite Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cellulite Treatment Market Opportunities
  • 3.4. Cellulite Treatment Market Future Trends

4. Cellulite Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cellulite Treatment Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cellulite Treatment Market Landscape

  • 6.1. Cellulite Treatment Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cellulite Treatment Market - By Treatment Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Treatment Type, 2024 & 2032 (%)
    • 7.1.2. Non-Invasive
    • 7.1.3. Minimally Invasive
    • 7.1.4. Topical

8. Cellulite Treatment Market - By Gender

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Gender, 2024 & 2032 (%)
    • 8.1.2. Female
    • 8.1.3. Male

9. Cellulite Treatment Market - By Age Group

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Age Group, 2024 & 2032 (%)
    • 9.1.2. 18-30 years
    • 9.1.3. 31-45 years
    • 9.1.4. 46-60 years
    • 9.1.5. Above 60 years

10. Cellulite Treatment Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Dermatology Clinics
    • 10.1.4. Aesthetic Clinics/Medical Spas
    • 10.1.5. Home Use

11. Cellulite Treatment Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Cellulite Treatment Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Cellulite Treatment Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Cellulite Treatment Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Cellulite Treatment Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Cellulite Treatment Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Cellulite Treatment Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. AbbVie Inc. (Allergan Aesthetics)
    • 12.2.2. Lumenis Ltd.
    • 12.2.3. Candela Medical
    • 12.2.4. Solta Medical
    • 12.2.5. Cynosure LLC
    • 12.2.6. BTL Aesthetics
    • 12.2.7. Cutera Inc.
    • 12.2.8. Merz Pharmaceuticals
    • 12.2.9. Endo International plc
    • 12.2.10. Venus Concept Inc.
    • 12.2.11. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us